In recent years, advances in imaging technologies and molecular biology have shed new light on the mechanisms underlying Flash Brown. A 2020 study published in the Journal of Investigative Dermatology employed advanced imaging techniques, such as reflectance confocal microscopy, to examine the skin of individuals with Flash Brown. The authors observed a significant increase in melanin content and a corresponding decrease in skin reflectance, confirming the suspected role of melanin in the condition.

While Flash Brown is generally considered a benign condition, its transient and unpredictable nature can cause significant distress and anxiety for affected individuals. Currently, there is no established treatment for Flash Brown, and management strategies are largely focused on alleviating symptoms and reducing the frequency of episodes.

Some clinicians have reported success with topical creams or oral medications aimed at reducing melanin production or modulating the nervous system. However, these approaches are not universally effective, and the development of more targeted and evidence-based treatments remains a pressing need.